Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial.
Journal Information
Full Title: World Allergy Organ J
Abbreviation: World Allergy Organ J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of competing interest Jonny G. Peter has received research funding from BioCryst Pharmaceuticals, Inc. Dianne Tomita and Phil Collis are employees of, and own stocks in, BioCryst Pharmaceuticals, Inc. Bhavisha Desai is a former employee of BioCryst Pharmaceuticals, Inc. Marcin Stobiecki has received research funding from BioCryst Pharmaceuticals, Inc."
Funding Disclosure
Evidence found in paper:
"Funding source This study and the development of this manuscript were funded by BioCryst Pharmaceuticals, Inc."
Protocol Registration
Evidence found in paper:
"Clinical trial registration NCT03472040. Retrospectively registered March 21, 2018."
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025